MedscapeCME Cardiology Podcast
By MedscapeCME
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Podcast Description
Medscape offers free CME activities for physicians and other health professionals. Medscape is organized by medical specialty, with each supported specialty having its own customized Web site. Specialty content is evaluated, created, and presented under the guidance of a Medscape program director and a medical professional advisory board.
| Name | Description | Released | Price | ||
|---|---|---|---|---|---|
|
1 |
Breaking Down Symptomatic DVT: Treatment Gaps in Recurrent Disease | Novel oral anticoagulants hold the promise of simplifying the treatment of acute and recurrent VTE; Drs Turpie, Agnelli, and Cohen discuss recent findings. | 1/23/12 | Free | View In iTunes |
|
2 |
New Stent Technologies: Clinical Applications of Evidence-Based Medicine | Drs. Meredith and Stone wrap up the hot topics in new developments in stent design from TCT 2011. | 1/10/12 | Free | View In iTunes |
|
3 |
Highlight on CETP: Role in Lipid Metabolism and Homeostasis | Join Dr. Rader as he discusses whether a change in HDL cholesterol level reflects proper HDL particle function or therapeutic success. And DISCUSS this topic with Dr. Rader. | 12/23/11 | Free | View In iTunes |
|
4 |
Advanced Prostanoid Therapy in PAH: The Time to Be Proactive Is Now! | Drs. Waxman, Frantz, and Chakinala discuss barriers to the use of prostanoid therapy in PAH management and when and how to use prostanoids. | 12/22/11 | Free | View In iTunes |
|
5 |
Addressing Residual Risk in the ACS Patient: Knowing the Numbers | Join Drs. Chapman, Gotto, and Kastelein as they discuss the results of AIM-HIGH and the latest CETP inhibitor clinical trials in HDL-targeted residual cardiovascular risk reduction. | 12/21/11 | Free | View In iTunes |
|
6 |
TAVI in the USA | After the PARTNER trial, the 2 PIs of the other US trial on transcatheter valves, Drs. Popma and Adams, give their take on stateside TAVI. | 12/21/11 | Free | View In iTunes |
|
7 |
Developments in the Treatment of Dyslipidemia: Are All Omega-3 Fatty Acids the Same? | Join our experts Drs. Miller, Schaefer, Jacobson, and Bays as they discuss current and future management of the patient with hyperlipidemia. | 12/20/11 | Free | View In iTunes |
|
8 |
HDL Quality: Is It a Better Target Than HDL-C? | Join Dr. Nicholls as he discusses the clinical significance of HDL-C for residual cardiovascular risk and whether HDL functionality would be a better predictor of therapeutic success. And DISCUSS this topic with Dr. Nicholls on Medscape Discuss. | 12/19/11 | Free | View In iTunes |
|
9 |
Innovations in Cardiac PET Imaging | Review recent advances in positron emission tomography and its impact on clinical practice. | 12/19/11 | Free | View In iTunes |
|
10 |
Mineral Homeostasis in CKD - Mineral and Bone Disorder: Evolving Concepts in Prevention and Treatment | Drs. Geoffrey Block, David Spiegel, Munro Peacock, and Kathleen Hill discuss calcium balance in CKD-MBD, including implications of new data. | 12/15/11 | Free | View In iTunes |
|
11 |
The Importance of Catheterization in the Assessment of Pulmonary Hypertension | Dr Krasuski highlights the pivotal role of RHC in the diagnosis and management of PAH. | 12/15/11 | Free | View In iTunes |
|
12 |
TCT 2011: Interventional Hot Topics | PARTNER, RIFLE, novel DES, and renal denervation – Drs. Worthley and Meredith give their take on the hot topics for the interventionalist. | 12/15/11 | Free | View In iTunes |
|
13 |
Prevention of Surgical Fires | Surgical fires can have a devastating impact on patients, but they may be preventable by understanding their causes and implementing risk-reduction strategies. | 12/15/11 | Free | View In iTunes |
|
14 |
Lipid Treatment Strategies in Patients With HIV: Statin Therapy Case Challenge | Join Drs. Underberg and Waters as they discuss dyslipidemia in patients with HIV, selection of statin therapy, and drug-drug interactions. | 12/14/11 | Free | View In iTunes |
|
15 |
Organizing Stroke Care for Optimal Outcomes: Risky Business | Examine strategies to streamline care in the emergency department, resulting in improved survival and enduring quality of life. | 12/14/11 | Free | View In iTunes |
|
16 |
Black and White: Racial Disparities in the Treatment of Patients With CAD | Drs. Smith and Batchelor review possible reasons for poorer outcomes in black patients undergoing stent implantation. | 12/13/11 | Free | View In iTunes |
|
17 |
Biomarker-Guided Therapy for Heart Failure: Does Age Matter? | Join Drs. Felker, Piña, and Januzzi as they discuss the use of cardiac biomarkers to gauge therapeutic success in different age groups. | 12/9/11 | Free | View In iTunes |
|
18 |
The Role of the Cardiologist in Managing Type 2 Diabetes: Getting to the Heart of the Matter | Darren McGuire, MD, explores the relationship between type 2 diabetes and diabetes therapies on CV risk in this interactive program. | 12/9/11 | Free | View In iTunes |
|
19 |
HDL-C and AIM-HIGH: Does Increasing HDL-C Reduce Cardiovascular Risk? | Join Drs. Davidson, Toth, and Boden as they discuss the results of the AIM-HIGH trial and its implications on the treatment of low HDL-C with currently available agents. | 12/8/11 | Free | View In iTunes |
|
20 |
Antiarrhythmics for Atrial Fibrillation: Practical Implications of Latest Clinical Developments | Repercussions from the surprising results from PALLAS. Drs. Camm, Connolly, and Le Heuzey discuss implications for patient care. | 12/8/11 | Free | View In iTunes |
|
21 |
HDL and CHD: New Mechanisms Targeting Risk | Join Drs. Eckel, Ridker, and Cannon for a panel discussion on the relationship among LDL-C, low HDL-C, and therapies in development targeting residual CV risk. | 12/6/11 | Free | View In iTunes |
|
22 |
2011 Guidelines: Focus on Antiplatelet Therapies | Updated guidelines on use of antiplatelet agents in ACS. Drs. Bates, James, Montelescot, and Storey discuss the winners and losers. | 11/30/11 | Free | View In iTunes |
|
23 |
Balancing CV and GI Risk: Expert Perspectives | Aspirin increases bleeding; rates are higher with dual therapy. But stopping antiplatelets increases cardiovascular events. Drs. Mehran and Scheiman discuss how to strike the right balance. | 11/29/11 | Free | View In iTunes |
|
24 |
Managing Metabolic and Regulatory Disturbances of Chronic Kidney Disease: The Health Care Team Approach | Achieve optimal outcomes in the patient with CKD by managing mineral and bone disturbances through a consistent team strategy. | 11/29/11 | Free | View In iTunes |
|
25 |
Statin Intolerance in the Elderly: Solutions for Complex Cases | Join Drs. Fuster, Barter, and Toth as they discuss the challenges of identifying statin intolerance in elderly patients and how to manage it effectively. | 11/28/11 | Free | View In iTunes |
|
26 |
Endothelial Function and Cardiovascular Health: From Hypothesis to Treatment | Do therapies that promote nitric oxide release improve endothelial dysfunction? Drs. Weber, Mason, Cockcroft, and Fonseca review the latest data. | 11/28/11 | Free | View In iTunes |
|
27 |
ACS Clinical Trials and Registries Using Antiplatelet Agents: Where Does the Truth Lie? | Clinical trials and registries. Do we need both? Drs. Lopes and Peterson discuss how to interpret and apply the data in clinical practice. | 11/23/11 | Free | View In iTunes |
|
28 |
Markers and Mediators of Managing Hyponatremia in Chronic Heart Failure | Hyponatremia equals low sodium. But how low is low? Drs. Carson and Piña discuss when and how to intervene in a setting of chronic heart failure. | 11/23/11 | Free | View In iTunes |
|
29 |
Switching Antiplatelet Therapies: Case-Based Guidance on the Use of Platelet Testing | Hitting the sweet spot for antiplatelet efficacy. Is platelet reactivity the answer? Drs. Lopes and Becker explore the possibilities. | 11/22/11 | Free | View In iTunes |
|
30 |
Appropriate Screening, Diagnosis, and Management of PAH: Revealing and Addressing Treatment Gaps | Join our experts, Drs. McLaughlin, McGoon, and Tapson, as they discuss improved medical developments for treating patients with PAH. | 11/18/11 | Free | View In iTunes |
|
31 |
Dilemmas in Diabetes and Cardiovascular Disease: Positioning PPAR Agonists to Address the Big Picture | Join Drs. Betteridge and Charbonnel as they discuss PPAR agonists in development and their potential in cardiovascular risk reduction. | 11/17/11 | Free | View In iTunes |
|
32 |
Hyponatremia in Heart Failure: Causes, Consequences, and Treatments | What could be worse than heart failure? Try heart failure with hyponatremia. | 11/15/11 | Free | View In iTunes |
|
33 |
Making Medicare Preventive Services Part of Your Practice | During annual visits, make time to plan necessary screening and review the patient's overall health needs. | 11/8/11 | Free | View In iTunes |
|
34 |
Polypharmacy and Statin Selection: Reducing the Potential for Drug-Drug Interactions | Join Drs. Foody and Dall as they discuss managing statin intolerance, drug-drug interactions, and statin therapy selection in patients with dyslipidemia. | 11/7/11 | Free | View In iTunes |
|
35 |
HDL: The Next Frontier in Reducing Atherosclerosis and Cardiovascular Risk in Type 2 Diabetes? | Join Drs. Bruckert, von Eckardstein, and Stalenhoef as they discuss the latest data on reducing residual cardiovascular risk in patients with type 2 diabetes. | 11/1/11 | Free | View In iTunes |
|
36 |
Antiplatelets in ACS: Expanding Choices | With the recent approval of a third P2Y12 inhibitor, how should new agents be integrated into practice? Dr. Storey leads a case-based discussion with Drs. Geisler, Mehta, and Wiviott. | 10/21/11 | Free | View In iTunes |
|
37 |
Individualizing Treatment Targets and Choice of Medication in Type 2 Diabetes: Incretin-Based Therapies | Drs. Julio Rosenstock, Silvio Inzucchi, and Robert Ratner discuss new data from EASD 2011 and the role of individualizing diabetes care. | 10/21/11 | Free | View In iTunes |
|
38 |
Minimizing Stroke in TAVI | Stroke rates are higher with transcatheter aortic valve implantation vs surgical valve replacement. Dr. Windecker discusses possible explanations and strategies to minimize stroke with surgeon Dr. Kappetein. | 10/12/11 | Free | View In iTunes |
|
39 |
Can Targeting CETP Halt Atherosclerosis Progression? Examining the Evidence | Join Drs. Tardif and Fayad for a discussion of the latest clinical trials in HDL-C-modifying therapy. | 10/3/11 | Free | View In iTunes |
|
40 |
NSTEMI Guidelines: Are the US and Europe in Harmony? | Dr. White asks Drs. Ohman and Fox about the similarities and differences between the 2 sets of guidelines. | 9/29/11 | Free | View In iTunes |
|
41 |
Secondary Stroke Prevention in AF: Impact and Burden on Practice and Healthcare Systems | Drs. Eikelboom, Bode, and Hankey discuss how novel anticoagulants will improve outcomes for patients with AF who have had a stroke. | 9/28/11 | Free | View In iTunes |
|
42 |
HDL Targeting Therapies - Updates from the European Society of Cardiology | View this discussion from ESC on recent clinical trial safety data regarding HDL functionality and the implications of HDL modulation | 9/28/11 | Free | View In iTunes |
|
43 |
Optimizing Outcomes for At-Risk Patient Groups Using a Multibiomarker Approach | Personalization of medical care using a biomarker approach. The future is almost here. Drs. Piña, Januzzi, Felker, and O'Connor discuss biomarkers old and new in the management of heart failure. | 9/27/11 | Free | View In iTunes |
|
44 |
Fibrosis and Heart Failure: The Use of Cardiac Biomarkers to Gauge Therapeutic Success | Join our experts, Drs. Januzzi, Gullestad, and de Boer, as they discuss the use of cardiac biomarkers to gauge therapeutic success. | 9/27/11 | Free | View In iTunes |
|
45 |
Pathophysiology of Severe Familial Hypercholesterolemia: The Role of Apo B | Join Drs. Ballantyne, Tsimikas, and Bruckert for a discussion on the pathophysiology and management of severe FH. | 9/26/11 | Free | View In iTunes |
|
46 |
The Complex Case of...NSTEMI in a Patient With Diabetes and Multivessel Disease | Dr. Uren presents a complex case to Dr. Silber who quizzes him on strategy and what he would have done differently with the benefit of hindsight. | 9/26/11 | Free | View In iTunes |
|
47 |
Evaluating the Data: What Recent Clinical Trials Can Teach Us About Preventing Atrial Fibrillation-Related Stroke | Join Drs. Lindsay, Lip, Fox, and Alexander as they discuss recent anticoagulant trials in the prevention of atrial fibrillation-related stroke. | 9/23/11 | Free | View In iTunes |
|
48 |
A Case-Based Approach to Improve Strategies to Reduce Risk for SCA Post-PCI | At risk for SCA after PCI -- no problem -- insert an ICD, right? Not so fast. The rationale behind why you may not get reimbursed. What are the alternatives? | 9/20/11 | Free | View In iTunes |
|
49 |
HDL-C in the Spotlight: Modulating CETP to Reduce Cardiovascular Risk | Join Drs. Chapman, Brewer, and Deanfield for a discussion on low HDL-C and the potential role CETP inhibitors may play in reducing residual cardiovascular risk. | 9/19/11 | Free | View In iTunes |
|
50 |
The Complex Case of...The Patient With Angina and Chronic Total Occlusion | How do you decide if a CTO should be opened? Dr. Feres presents a complex case and asks questions of Dr. Lasave and the audience along the way. | 9/12/11 | Free | View In iTunes |
| Total: 50 Episodes |
